Table 1.
# | Oligonucleotide/ small molecule |
Mechanism of action/Target |
Modification | Stability in biofluids |
Specificity | Uptake efficacy |
Ref |
---|---|---|---|---|---|---|---|
1 | MO-DM2 | Antisense/r(CCUG) repeat expansion | morpholino | ++ | +++ | ++ | 49 |
2 | PMO-CPP | antisense | morpholino | nd | nd | +++ | 50 |
3 | P-gp siRNA | siRNA/reducing Pgp expression in breast cancer | “Clicked” triblock copolymer, natural siRNA | + | ++ | +++ | 51 |
4 | CD206-siRNA | siRNA/macrophage targeted delivery | Micelle mannosylation by click | ++ | +++ | +++ | 52 |
5 | LW6 | HIV-1 α supressing | Click with a fluorophore | nd | nd | +++ | 53 |
6 | D/Gal | Induced gene expression/cancer cell | Clicked galactose | nd | ++ | ++ | 54 |
7 | ADC | anti-CD22 antibody with doxorubicin/lymph oma cancer cell | - | ++ | +++ | +++ | 55 |
+ Moderate, ++ High, +++ Very high